The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems ... Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a global giant making genome sequencing equipment.

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

Regeneron and Illumina have joined a major investment ... drug discovery and transform patient care." After the initial sequencing, the biospecimens will be stored to support future multi-omics ...

A review examines how quorum sensing, a bacterial communication system, shapes marine eukaryote interactions, influencing processes such as development, disease pathogenesis, and microbiome ...